UCB has opened its UCB Solution Accelerator, an environment designed to drive collaboration with the Georgia Tech community to develop solutions for those living with severe diseases. The 2,500-square foot innovation center will be located in Atlanta’s Centergy Building at Technology Square.
 
UCB is a global biopharmaceutical company focused on developing medicines to treat severe diseases of the immune and central nervous system. Its North America headquarters are located in Smyrna, GA.
 
“Establishing a presence in Technology Square is a natural extension of our existing relationship with Georgia Tech,” said Jeff Wren, head of UCB’s Neurology Patient Value Unit. “We are thrilled to join this vibrant innovation community to learn and grow our own capabilities. We are confident that co-location and proximity to the Georgia Tech community will enable us to quickly develop quality solutions that will create real value for the patients we serve.”
 
For the past year, UCB has collaborated with Georgia Tech’s Interoperability & Integration Innovation Lab (I3L) in using predictive analytics help address how to better fit medications to patients and positively impact patient care.
 
“We are delighted to welcome UCB as the first pharmaceutical company to join the growing innovation ecosystem in Tech Square,” said Georgia Tech President G. P. “Bud” Peterson. “We have already begun several collaborations with the company, and look forward to future opportunities for Georgia Tech students, faculty, and staff to help develop solutions to positively impact patient care for those living with chronic, severe diseases.”